| |
|
|
|
Spring Bank Pharmaceuticals Inc.  
|
|
13.47 0.39 (0.03%) |
07-06 16:00 |
|
Open: |
14.72 |
Pre close: |
13.08 |
Target:
|
1.95 
|
|
High: |
14.76 |
Low: |
13.4 |
Resistance:
|
1.67
1.84
|
|
Volume: |
2,080,228 |
Market Cap: |
1520M |
Support:
|
1.40
1.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.49
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.59 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
1.34 |
Stochastic Oscillator |
%K(14,3):
|
13.74 |
|
MA(250): |
2.46 |
%D(3): |
9.13 |
|
Average Volume(K) |
3-Month: |
13553
|
52-Week |
High:
|
5.70 |
|
10-Days: |
3799 |
Low: |
0.80 |
|
RSI |
RSI(14):
|
48.10 |
Change(%): |
-66.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.644 |
Return on Equity (ttm) |
-67.8 |
Shares Out. (M) |
17.09 |
|
EPS Est. Current Year |
-2.540 |
Return on Assets (ttm) |
-34.2 |
Shares Float (M) |
14.76 |
|
EPS Est. Next Year |
-2.260 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.97 |
|
EPS Est. Next Quarter |
-0.510 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
32.18 |
|
Forward EPS |
-1.880 |
Gross Profit (p.s.) |
-0.071 |
Shares Short (K) |
71 |
|
Book Value (p.s.) |
1.710 |
EBITDA (p.s.) |
-1.899 |
P/E |
-0.94 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.90 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-29.45 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.03 |
P/CF |
-0.89 |
|
|
|
|
|
|
